Tracking Medicare news, policy, and coverage changes.
Imprivata CEO Fran Rosch said AI agents should be treated similarly to the way hospitals treat a new contract nurse — vetted, monitored and then cut off as soon as the job is done. The post Imprivata CEO: AI Agents…
Read full article →(MedPage Today) -- The unique dual inflammation blockade of investigational lunsekimig showed promise for moderate-to-severe asthma in the phase II AIRCULES study. Targeting both thymic stromal lymphopoietin (TSLP) and interleukin (IL)-13, lunsekimig...
Read full article →(MedPage Today) -- Adding the BCL2 inhibitor venetoclax (Venclexta) to chemoimmunotherapy led to worse outcomes and excess mortality in patients with newly diagnosed double-hit lymphoma, phase II results from a randomized trial showed. Median...
Read full article →(MedPage Today) -- New multiple sclerosis (MS) patients treated with B-cell-depleting drugs or high-efficacy therapies had lower relapse rates and fewer brain lesions than those treated with oral drugs, but at 2 years, disability outcomes were...
Read full article →President Trump’s surgeon general nominee reported investments in the tobacco company Philip Morris International as well as beverage companies Monster Beverage Corp., Coca Cola Co. and Pepsi Co., according to financial disclosures released Thursday. Nicole Saphier disclosed these investments in…
Read full article →The CDC said it has received a rise in reports of human rabies exposure cases this summer, prompting an alert to healthcare providers.
Read full article →The legal basis for the $500 checks, and who would get them, isn't entirely clear.
Read full article →Platinum chemotherapy aged the liver cells of treated children, making them look more like adult liver cells and possibly raising the long-term risk of new tumors
Read full article →This week on "The Readout LOUD" podcast: Two experimental drugs were heralded as the next era in heart disease treatment — why did they fail?
Read full article →There has been rancorous debate over doctors accepting free gifts and speaking fees from pharma companies. That doesn't mean doctors have reconsidered.
Read full article →(MedPage Today) -- In cystic fibrosis, vanzacaftor-tezacaftor-deutivacaftor (VTD; Alyftrek) showed great potential for modifying the progression of disease in young children, according to the TIMBERLINE study. Assessing safety and tolerability...
Read full article →(MedPage Today) -- The graduate medical education (GME) software company Thalamus filed a lawsuit against its competitor Liaison International and ob/gyn leader Maya Hammoud, MD, MBA, over alleged anticompetitive conduct. Thalamus brought the...
Read full article →